
Arcutis Biotherapeutics Inc (ARQT) Stock: Assessing the Risk and Reward
The stock of Arcutis Biotherapeutics Inc (ARQT) has gone down by -8.89% for the week, with a -5.00% drop in the past month and a
The stock of Arcutis Biotherapeutics Inc (ARQT) has gone down by -8.89% for the week, with a -5.00% drop in the past month and a
The stock of Arcutis Biotherapeutics Inc (ARQT) has gone up by 6.06% for the week, with a -4.64% drop in the past month and a
The stock price of Arcutis Biotherapeutics Inc (NASDAQ: ARQT) has plunged by -1.54 when compared to previous closing price of 14.91, but the company has
The stock has a 36-month beta value of 1.86. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 3 as
In the past week, ARQT stock has gone down by -0.11%, with a monthly decline of -19.15% and a quarterly plunge of -0.04%. The volatility
The 36-month beta value for ARQT is at 1.79. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 3
The stock of Arcutis Biotherapeutics Inc (ARQT) has seen a 0.79% increase in the past week, with a 23.88% gain in the past month, and
The stock has a 36-month beta value of 1.69. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 3 as
Moreover, the 36-month beta value for ARQT is 1.72. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 3
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.